Related Experiment Videos
Heparin-coated cardiopulmonary bypass circuits: hemostatic alterations and postoperative blood loss
W R Wagner1, P C Johnson, K A Thompson
1Department of Surgery, University of Pittsburgh, Pennsylvania.
Insights
Heparin-coated bypass circuits did not significantly alter patient outcomes or hemostatic markers compared to standard circuits in coronary artery bypass grafting. Platelet activation occurs mainly from cardiopulmonary bypass circuitry contact.
Area of Science:
- Cardiovascular Surgery
- Biomaterials Science
- Hemostasis and Thrombosis
Background:
- Cardiopulmonary bypass (CPB) circuitry can activate platelets and the coagulation system.
- Heparin-coated circuits aim to reduce adverse hemostatic events during CPB.
- Understanding hemostatic alterations is crucial for optimizing patient outcomes in cardiac surgery.
Purpose of the Study:
- To investigate if heparin-coated bypass circuits impact patient outcomes and hemostatic alterations.
- To compare heparin-coated circuits with standard uncoated circuits in isolated coronary artery bypass grafting (CABG).
Main Methods:
- Prospective, randomized study comparing heparin-coated (n=10) versus uncoated (n=10) bypass circuits.
- Assessed postoperative blood loss, transfusion needs, routine coagulation tests, and specific immunoassays.
- Measured platelet activation markers (platelet factor 4, beta-thromboglobulin) and markers of thrombin generation and fibrinolysis.
Main Results:
- No significant differences in blood loss, transfusion requirements, or routine coagulation tests between groups.
- Immunoassays showed no significant differences, though trends suggested lower platelet secretion with heparin coating.
- Platelet activation increased during CPB in both groups; thrombin generation and fibrinolysis increased significantly after reperfusion.
Conclusions:
- Heparin-coated bypass circuits did not demonstrate significant clinical or hemostatic advantages over standard circuits in this study.
- Platelet activation is primarily induced by contact with the CPB circuitry.
- Significant thrombin generation and fibrinolytic activity are associated with heart and lung reperfusion post-CPB.
Abstract:
This prospective, randomized study involving patients undergoing isolated coronary artery bypass grafting investigated whether the use of heparin-coated bypass circuits with an uncoated cardiotomy reservoir (n = 10) compared with standard uncoated bypass circuits (n = 10) resulted in differences in patient outcome and hemostatic alterations. There were no differences in postoperative blood loss, transfusion requirements, and routine coagulation test results between groups. Immunoassays for platelet alpha-granule constituents platelet factor 4 and beta-thromboglobulin, thrombin generation by-product F1.2, fibrinopeptide A, thrombin-antithrombin complex, and fibrinolysis by-product D-dimer also demonstrated no significant differences between groups, although trends for lower platelet secretion with heparin coating were noted. Increases were found in beta-thromboglobulin and platelet factor 4 concentrations at 10 (p < 0.03) and 30 minutes (p < 0.001) of CPB, respectively, and continuing throughout CPB (p < 0.001) for both groups versus values measured before incision. No significant differences were seen between levels 5 minutes prior to aortic cross-clamp release and those obtained 8 and 45 minutes after cross-clamp release. Conversely, no significant increases in F1.2, thrombin-antithrombin complex, and D-dimer were seen prior to release of the aortic cross-clamp, but afterward increases occurred that were highly significant (p < 0.001). The temporal data suggest that platelet activation occurs primarily as a result of contact with the cardiopulmonary bypass circuitry, whereas thrombin generation and fibrinolytic activity are not significant until reperfusion of the heart and lungs.(ABSTRACT TRUNCATED AT 250 WORDS)